DE VINCENTIS, ANTONIO
 Distribuzione geografica
Continente #
AS - Asia 5.739
NA - Nord America 2.776
EU - Europa 1.035
SA - Sud America 331
Continente sconosciuto - Info sul continente non disponibili 81
AF - Africa 50
OC - Oceania 11
Totale 10.023
Nazione #
SG - Singapore 4.278
US - Stati Uniti d'America 2.659
CN - Cina 601
IT - Italia 582
HK - Hong Kong 281
BD - Bangladesh 238
BR - Brasile 223
VN - Vietnam 129
FR - Francia 115
GB - Regno Unito 110
DE - Germania 69
CA - Canada 53
IN - India 53
AR - Argentina 36
MX - Messico 36
NL - Olanda 30
TR - Turchia 24
ID - Indonesia 20
FI - Finlandia 19
EC - Ecuador 18
PL - Polonia 18
CO - Colombia 17
CZ - Repubblica Ceca 17
JP - Giappone 17
VE - Venezuela 16
ZA - Sudafrica 15
UA - Ucraina 12
IQ - Iraq 11
AU - Australia 10
EG - Egitto 10
PH - Filippine 10
SA - Arabia Saudita 10
KE - Kenya 9
MY - Malesia 9
PK - Pakistan 9
PT - Portogallo 8
CL - Cile 7
CR - Costa Rica 7
ES - Italia 7
RO - Romania 7
RU - Federazione Russa 7
NP - Nepal 6
PE - Perù 6
HN - Honduras 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
IE - Irlanda 4
SE - Svezia 4
TT - Trinidad e Tobago 4
XK - ???statistics.table.value.countryCode.XK??? 4
BH - Bahrain 3
CH - Svizzera 3
GT - Guatemala 3
JM - Giamaica 3
KR - Corea 3
LB - Libano 3
LT - Lituania 3
MD - Moldavia 3
PY - Paraguay 3
TN - Tunisia 3
AM - Armenia 2
AT - Austria 2
AZ - Azerbaigian 2
BO - Bolivia 2
BY - Bielorussia 2
DZ - Algeria 2
EE - Estonia 2
ET - Etiopia 2
IR - Iran 2
JO - Giordania 2
KZ - Kazakistan 2
PS - Palestinian Territory 2
RS - Serbia 2
SN - Senegal 2
SV - El Salvador 2
TH - Thailandia 2
UY - Uruguay 2
AL - Albania 1
BE - Belgio 1
BF - Burkina Faso 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
FK - Isole Falkland (Malvinas) 1
GN - Guinea 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
KH - Cambogia 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MA - Marocco 1
MN - Mongolia 1
MS - Montserrat 1
MU - Mauritius 1
Totale 9.936
Città #
San Jose 580
Ashburn 560
Singapore 438
Rome 338
Hong Kong 276
Hefei 183
Beijing 175
Council Bluffs 127
Columbus 102
Dallas 93
Boardman 91
Lauterbourg 88
Phoenix 78
Santa Clara 68
London 67
Shanghai 63
Los Angeles 60
New York 56
Ho Chi Minh City 50
Munich 39
Mexico City 30
Hanoi 27
Milan 24
Buffalo 22
Chicago 22
San Francisco 20
Amsterdam 18
São Paulo 18
Brno 16
Naples 15
Orem 15
Turku 15
Boston 14
Montreal 14
Toronto 14
Pune 13
Seattle 13
Tokyo 13
Paris 12
Warsaw 12
Washington 12
Brooklyn 10
Las Vegas 10
Brasília 8
Charlotte 8
Chennai 8
Denver 8
Lisbon 8
Manchester 8
Nairobi 8
Rio de Janeiro 8
Turin 8
Bari 7
Boydton 7
Cairo 7
Haiphong 7
Quito 7
Redmond 7
Frankfurt am Main 6
Guangzhou 6
Guayaquil 6
Istanbul 6
Johannesburg 6
Pasadena 6
Atlanta 5
Bucharest 5
Canberra 5
Caracas 5
Detroit 5
Houston 5
Lahore 5
Miami 5
Philadelphia 5
Riyadh 5
San José 5
Barquisimeto 4
Bogotá 4
Bologna 4
Buenos Aires 4
Chaguanas 4
Curitiba 4
Da Nang 4
Hangzhou 4
Helsinki 4
Kochi 4
Melbourne 4
New Delhi 4
Newark 4
Poplar 4
Pristina 4
Taranto 4
Tashkent 4
Trieste 4
Verona 4
Ascoli Piceno 3
Bedford 3
Belo Horizonte 3
Birmingham 3
Cagliari 3
Campinas 3
Totale 4.210
Nome #
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 271
A Functional and Immunologic Point of View on Corneal Endothelial Transplantation: A Systematic Review and Meta-Analysis 247
Management of hip fracture in the older people: rationale and design of the Italian consensus on the orthogeriatric co-management 246
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 245
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study 240
Chronic cough in adults: recommendations from an Italian intersociety consensus 238
Combined evaluation of aminotransferases improves risk stratification for overall and cause-specific mortality in older patients 231
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis 223
Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 223
Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study 221
BREATH PRINT ANALYSIS BY E-NOSE IS ASSOCIATED WITH ADVERSE OUTCOMES OF CIRRHOTIC PATIENTS INDEPENDENTLY FROM THE OTHER PROGNOSTIC INDICES 215
The hepatic expression of lysosomal acid lipase (LAL) is reduced in NAFLD patients, and associated with features of genetically determined LAL deficiency and NAFLD activity score 214
Assessment of liver function by the exhaled breath-print during chronic liver disease 210
THU-390 - Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 181
Cardiotrophin-1 is not associated with carotid or coronary disease and is inversely associated with obesity in patients undergoing coronary angiography 178
Orthogeriatric co-management for the care of older subjects with hip fracture: recommendations from an Italian intersociety consensus 175
Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery 164
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 163
Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination 156
Exhaled breath analysis in hepatology: State-of-the-art and perspectives 149
Return to Sport after Anatomic and Reverse Total Shoulder Arthroplasty in Elderly Patients: A Systematic Review and Meta-Analysis 148
Acoustic Radiation Forced Impulse of the Liver and the Spleen, Combined with Spleen Dimension and Platelet Count in New Ratio Scores, Identifies High-Risk Esophageal Varices in Well-Compensated Cirrhotic Patients 147
Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease 144
Association between non-invasive liver fibrosis scores and occurrence of health adverse outcomes in older people 140
A challenging alfa-fetoprotein in a cirrhotic patient 139
Gut Microbiota and Related Electronic Multisensorial System Changes in Subjects With Symptomatic Uncomplicated Diverticular Disease Undergoing Rifaximin Therapy 138
Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age 133
A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease 130
Appropriateness of direct oral anticoagulant prescribing in older subjects with atrial fibrillation discharged from acute medical wards 123
Diagnostic value of Virtual Touch Quantification (VTQ®) for differentiation of hemangiomas from malignant focal liver lesions 122
The PNPLA3 rs738409 variant can increase the risk of liver toxicity in multiple sclerosis patients treated with beta-interferon 122
Authors' Reply to Brunetti et al. "Potentially Inappropriate Medications, Drug-Drug Interactions, and Anticholinergic Burden in Elderly Hospitalized Patients: Does an Association Exist with Post-Discharge Health Outcomes?" 120
Breathprinting of liver diseases 120
Analysis of volatile organic compounds: an innovative approach to heart failure characterization in older patients 120
A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores 119
ALT levels are associated with metabolic parameters and age in a large real-life population. 117
Association between clinical scores of liver fibrosis and adverse non-hepatic outcomes: The key in the holistic vision of the patient 112
Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis 107
Combining genetic variants to improve risk prediction for nafld and its progression to cirrhosis: a proof of concept study 105
Essays on quality of therapy and impact of comorbidities in older hospitalized subjects 99
Clinical outcomes and phenotypes of respiratory failure in older subjects admitted to an acute care geriatric hospital ward 95
Prevalence, risk factors, and treatment of anemia in hospitalized older patients across geriatric and nephrological settings in Italy 94
Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis 87
Non‐invasive assessment of hepatic steatosis by ultrasound‐derived fat fraction in individuals at high‐risk for metabolic dysfunction‐associated steatotic liver disease 84
The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patients 84
Hepatocellular carcinoma in alcoholic liver disease: current management and recent advances 81
Length of Hospital Stay after Total Knee Arthroplasty: A Correlation Study on 1200 Patients 80
Low Alanine Aminotransferase Levels in the Elderly Population: Frailty, Disability, Sarcopenia, and Reduced Survival 80
Potentially inappropriate medications, drug–drug interactions, and anticholinergic burden in elderly hospitalized patients: does an association exist with post-discharge health outcomes? 78
Lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology 78
Sarcopenia in Hepatocellular Carcinoma: Pathogenesis and Management 77
Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank 73
Deprescribing psychoactive drugs in older orthogeriatric patients: findings from the GIOG2.0 Italian survey 71
Rate of non-response to ursodeoxycholic acid in a large real-world cohort of primary biliary cholangitis patients in Italy 70
Poor accuracy and sustainability of the first-step FIB4 EASL pathway for stratifying steatotic liver disease risk in the general population 69
Prevalence, clinical characteristics, and disease burden of chronic cough in Italy: a cross-sectional study 69
Return to Sport Activity in the Elderly Patients after Unicompartmental Knee Arthroplasty: A Systematic Review and Meta-Analysis 68
Incidence and Outcome of Pneumomediastinum in Non-ICU Hospitalized COVID-19 Patients 68
Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens 67
Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease 65
Effect of sibutramine on plasma C-reactive protein, leptin and adiponectin concentrations: a systematic review and meta-analysis of randomized controlled trials 65
Correction: Deprescribing psychoactive drugs in older orthogeriatric patients: findings from the GIOG2.0 Italian survey 65
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 63
NAFLD FIBROSIS SCORE IS ASSOCIATED WITH CARDIOVASCULAR DISEASE IN PATIENTS UNDERGOING CORONAROGRAPHY 63
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 62
Impact of Low Muscle Mass and Low Muscle Strength According to EWGSOP2 and EWGSOP1 in Community-Dwelling Older People 61
Hepatic complications of bariatric surgery : the reverse side of the coin 61
Voltammetric analysis for distinguishing portal hypertension-related from malignancy-related ascites: A proof of concept study 61
Reply to the Letter: “Low levels of transaminase and mortality risk in older people with special reference to sarcopenia” 61
Inborn and acquired risk factors for severe liver disease in Europeans with type 2 diabetes from the UK Biobank 60
Molecular and histological traits of reduced lysosomal acid lipase activity in the fatty liver 59
Preoperative and Perioperative Predictors of Length of Hospital Stay after Primary Total Hip Arthroplasty-Our Experience on 743 Cases 59
Non-alcoholic fatty liver disease and steatohepatitis: State of the art on effective therapeutics based on the gold standard method for diagnosis 58
Microarray-based Detection of Critical Overexpressed Genes in the Progression of Hepatic Fibrosis in Non-alcoholic Fatty Liver Disease: A Protein-protein Interaction Network Analysis 55
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 54
Screening of obstructive sleep apnea syndrome by electronic-nose analysis of volatile organic compounds 54
A noninvasive strategy for multi-disease diagnosis via multi-sensor platform: integrative analysis of five years of exhaled breath-based diagnostics for seven diseases 52
Predicting risk of declining functional ability in community-dwelling older people 52
Individuation of presence and combination of genetic risk factors may help to refine the risk for most severe forms of NAFLD 52
Sleep disorders during the COVID-19 pandemic: Results from the second phase of web-based EPICOVID19 study 50
Haemorrhoidal disease in severe portal hypertension: a combined approach with transjugular intrahepatic portosystemic shunt (TIPS) and transanal haemorrhoidal dearterialization (THD) 50
Genetic variants in the MTHFR are not associated with fatty liver disease. 49
Platelet count may impact on lysosomal acid lipase activity determination in dried blood spot 49
E-nose discriminative ability within a highly homogeneous sample of respiratory diseases 49
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: Analysis of the REPOSI registry 47
The authors reply 47
Neurotrophic keratopathy: pros and cons of current treatments 46
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 46
Reply 43
Long noncoding RNAs in nonalcoholic fatty liver disease and liver fibrosis: state-of-the-art and perspectives in diagnosis and treatment 43
Liver Cirrhosis is Characterized by an Acquired Lysosomal Acid Lipase Deficiency Independent from the Etiology of Liver Disease 42
Prevalence of patatin-like phospholipase domain containing 3 (PNPLA3) rs738409 C/G polymorphism in patients with bona-fide post-NASH cirrhosis 36
Reply 35
Prevalence of anti-hepatitis C positivity in a nursing home: a hitherto unrecognized submerged population 35
PhenoAge and PhenoAgeAccel do not outperform chronological age in predicting physical performance decline or mortality in community-dwelling older adults 6
Totale 10.023
Categoria #
all - tutte 52.494
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.494


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022164 0 0 0 0 1 4 0 2 54 0 0 103
2022/202399 1 1 8 2 10 4 36 9 5 7 16 0
2023/2024316 11 27 15 36 39 120 0 10 4 16 12 26
2024/20254.616 57 25 87 19 75 96 87 25 217 291 1.633 2.004
2025/20263.688 295 148 222 344 132 202 956 214 252 329 307 287
2026/20271.130 60 340 449 281 0 0 0 0 0 0 0 0
Totale 10.023